Effects of soy-milk on blood lipids and total homocysteine level in postmenopausal women of Bangladesh
Journal: International Journal of Nutrition (Vol.2, No. 3)Publication Date: 2017-01-22
Authors : Farjana Rahman Bhuiyan; Farzana Saleh; Israt Ara Hossain; Khursheed Jahan; Liaquat Ali;
Page : 14-23
Keywords : Soy-milk; postmenopausal women; total homocysteine; total cholesterol; triglycerides; LDL-C; HDL-C; Bangladesh;
Abstract
Background: Isoflavones are phytoestrogens present in natural sources, and they resemble estradiol in structure and manner of action. The aim of the study was to assess the effects of soy-milk on serum tHcy levels and to assess the glycemic and lipidemic status of Bangladeshi postmenopausal women. Methods: Thirty-six women (aged 50 ±5.16 years, M ±SD) participated in a randomized, un-blinded, open-ended, crossover study design for 52 days. The soy-milk group consumed 350 mL of milk twice a day for 21- day; the milk contained ~30 mg of isoflavones. FBG, PPG, HbA1c, TC, TG, HDL-C, NEFA, and tHcy were measured on day 0, day 21, day 31, and day 52 with a 10- day washout period. Results: After the consumption of soy-milk, the level of HDL-C significantly (p=0.005) increased on day 21 in the subjects. No significant changes were observed between the groups. After crossover, significant changes in FBG (p=0.005) and TG (p=0.049) were observed on day 52 in the soy-milk group. Significant improvement in TG (p=0.001) and HDL-C (p=0.032) was also seen at the end-point. Conclusions: Soy isoflavones is to some extent favorable to reduce CVD risk factors among Bangladeshi postmenopausal women.
Other Latest Articles
- Risk factors for stunted growth among children aged 6–59 months in rural Uganda
- An optical chemical sensor for monitoring of nickel in waters and hydrogen peroxide samples
- Vibrational, UV, NBO analysis of E-[1-(3'-methylthienyl)-5-Phenyl-2, 4-Pentadiene-3-one] using Quantum Mechanical Computations and Experimental Spectra
- Vibrational Spectral Analysis And First Order Hyperpolarizability Calculations On (E)-N′-(furan-2-ylmethylene)nicotinohydrazide
- Pregnancy Outcome in Gestational Diabetes Mellitus under Treatment
Last modified: 2017-04-01 21:07:24